CARAWAY THERAPEUTICS
Rheostat’s mission is to invent novel treatments for neurodegenerative disease through modulation of mitophagy and autophagy. They believe that the degradation of toxic cellular components, whether they are damaged organelles or aggregated proteins, is a fundamental node of biology. Mutations that impair these clearance pathways cause multiple neurodegenerative diseases, many of which are associated with cognitive impairment. They aim to leverage our understanding of these critical pathways to discover and develop novel small molecules that will restore cellular balance and treat neurodegenerative and rare diseases.
CARAWAY THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.carawaytx.com
Total Employee:
11+
Status:
Active
Total Funding:
23 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS AWS Global Accelerator
Similar Organizations
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
Current Advisors List
Current Employees Featured
Founder
Investors List
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Caraway Therapeutics
MRL Ventures Fund
MRL Ventures Fund investment in Venture Round - Caraway Therapeutics
Dementia Discovery Fund
Dementia Discovery Fund investment in Series A - Caraway Therapeutics
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - Caraway Therapeutics
Mayo Clinic
Mayo Clinic investment in Series A - Caraway Therapeutics
SV Health Investors
SV Health Investors investment in Series A - Caraway Therapeutics
MRL Ventures Fund
MRL Ventures Fund investment in Series A - Caraway Therapeutics
Amgen Ventures
Amgen Ventures investment in Series A - Caraway Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Caraway Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2019-12-03 | Caraway Therapeutics Names Martin Williams as CEO |
Official Site Inspections
http://www.carawaytx.com Semrush global rank: 4.9 M Semrush visits lastest month: 1.78 K
- Host name: 247.13.197.104.bc.googleusercontent.com
- IP address: 104.197.13.247
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Caraway Therapeutics"
MSD to Acquire Caraway Therapeutics, Inc. - MSD
Nov 21, 2023 · Caraway Therapeutics is a biopharmaceutical company pursuing novel approaches for the treatment of genetically defined neurodegenerative and rare diseases. The …See details»
Merck to Acquire Caraway Therapeutics, Inc. - Merck.com
Nov 21, 2023 · The company is backed by top-tier investors, including SV Health Investors and its Dementia Discovery Fund, AbbVie Ventures, MRL Ventures Fund, Amgen Ventures, and Eisai Innovation. Caraway is based in …See details»
Caraway Therapeutics, Inc. | LinkedIn
Caraway is a leader in targeting these mechanisms with potentially disease-modifying compounds for patients suffering the devastating effects of neurodegenerative and rare diseases including...See details»
Merck to Acquire Caraway Therapeutics, Inc. | Business Wire
Nov 21, 2023 · Caraway Therapeutics is a biopharmaceutical company pursuing novel approaches for the treatment of genetically defined neurodegenerative and rare diseases. The …See details»
Caraway Therapeutics - Overview, News & Similar companies
Apr 11, 2023 · View Caraway Therapeutics (carawaytx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Merck to Acquire Caraway Therapeutics, Inc. - SV Health Investors
Nov 21, 2023 · The company is backed by top-tier investors, including SV Health Investors and its Dementia Discovery Fund, AbbVie Ventures, MRL Ventures Fund, Amgen Ventures, and Eisai …See details»
Merck To Acquire Caraway Therapeutics | Markets Insider
Nov 21, 2023 · (RTTNews) - Merck & Co Inc. (MRK) Tuesday announced its decision to acquire Caraway Therapeutics, Inc. for a total potential consideration of $610 million, including an …See details»
Caraway Therapeutics, Inc. Company Profile | Cambridge, MA ...
Find company research, competitor information, contact details & financial data for Caraway Therapeutics, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Merck to Acquire Caraway Therapeutics, Inc. - BioSpace
Nov 21, 2023 · Merck and Caraway Therapeutics, Inc. announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire …See details»
Caraway Therapeutics Establishes Collaboration with …
Jun 9, 2021 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Caraway Therapeutics today announced an exclusive, collaboration and option agreement with AbbVie (NYSE: ABBV) to develop and commercialize Caraway’s small...See details»
Caraway Therapeutics - Craft
Caraway Therapeutics is a company that discovers drugs for neurodegenerative diseases. It uses genetic data and biology to develop small molecules that activate neurons’ clearance and …See details»
Merck to acquire Caraway Therapeutics in up to $610M deal
Nov 21, 2023 · Merck is snapping up a private biotech focused on genetically defined neurodegenerative disorders and rare diseases, promising to pay $610 million if everything …See details»
Caraway Therapeutics to Present at Two Upcoming Investor …
Oct 7, 2022 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Caraway Therapeutics today announced that the Company will be participating in two upcoming investor conferences. “I …See details»
Caraway Therapeutics Establishes Collaboration with AbbVie to …
Jun 9, 2021 · CAMBRIDGE, Mass. -- (BUSINESS WIRE)-- Caraway Therapeutics today announced an exclusive, collaboration and option agreement with AbbVie (NYSE: ABBV) to …See details»
Caraway Therapeutics - PitchBook
Caraway Therapeutics is headquartered in Cambridge, MA. What is the size of Caraway Therapeutics? Caraway Therapeutics has 15 total employees. What industry is Caraway …See details»
Caraway Therapeutics to Present at 22 - Business Wire
Apr 12, 2023 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Caraway Therapeutics today announced that the Company will be participating in the 22 nd Annual Needham Healthcare …See details»
AbbVie and Caraway partner on Parkinson’s disease
Jun 11, 2021 · The Cambridge, Massachusetts–based start-up Caraway Therapeutics has partnered with AbbVie to develop a small molecule that modulates a potassium ion channel …See details»
Caraway Therapeutics to Present at the Oppenheimer Fall …
Sep 16, 2021 · Caraway is utilizing its unique product engine to develop proprietary insights into lysosomal function and small molecule ion channel modulation and advance a robust pipeline …See details»
Magdalene Moran - President & Chief Scientific Officer at ... - The …
Magdalene Moran, PhD, is a leading scientific researcher in the discovery and early development projects in multiple disease areas. She is a noted expert in the Transient Receptor Potential …See details»
Caraway Therapeutics Establishes Collaboration with AbbVie
Jun 9, 2021 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Caraway Therapeutics today announced an exclusive, collaboration and option agreement with AbbVie (NYSE: ABBV) to …See details»